Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse skin reactions following intravitreal bevacizumab injection.

Literature DB >> 22715260

Adverse skin reactions following intravitreal bevacizumab injection.

S Ameen¹, M Entabi, N Lee, A Stavrakoglou.

Abstract

The authors describe two separate cases of skin eruption following intravitreal bevacizumab injection with evidence to suggest that these were adverse drug reactions to bevacizumab. The authors also discuss how each case was treated and report on the final outcome.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 22715260 PMCID： PMC3062049 DOI： 10.1136/bcr.02.2010.2753

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

9 in total

1. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Authors: Philip J Rosenfeld; Anne E Fung; Carmen A Puliafito
Journal: Ophthalmic Surg Lasers Imaging Date: 2005 Jul-Aug

2. Complications in patients after intravitreal injection of bevacizumab.

Authors: Chiharu Shima; Hirokazu Sakaguchi; Fumi Gomi; Motohiro Kamei; Yasushi Ikuno; Yusuke Oshima; Miki Sawa; Motokazu Tsujikawa; Shunji Kusaka; Yasuo Tano
Journal: Acta Ophthalmol Date: 2007-11-17 Impact factor: 3.761

3. Testing intravitreal toxicity of bevacizumab (Avastin).

Authors: Roberta P A Manzano; Gholam A Peyman; Palwasha Khan; Muhamet Kivilcim
Journal: Retina Date: 2006-03 Impact factor: 4.256

4. Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors.

Authors: D T Alexandrescu; J G Vaillant; C A Dasanu
Journal: Clin Exp Dermatol Date: 2006-10-11 Impact factor: 3.470

9. Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer.

Authors: M Wasif Saif; Walter L Longo; Gary Israel
Journal: Clin Colorectal Cancer Date: 2008-03 Impact factor: 4.481

9 in total

1 in total

1. Cutaneous Cell-Mediated Delayed Hypersensitivity to Intravitreal Bevacizumab.

Authors: Anthony Fam; Paul T Finger
Journal: Middle East Afr J Ophthalmol Date: 2020-10-30

1 in total

Adverse skin reactions following intravitreal bevacizumab injection.

1. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

2. Complications in patients after intravitreal injection of bevacizumab.

3. Testing intravitreal toxicity of bevacizumab (Avastin).

4. Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors.

5. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

6. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

7. Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response.

8. Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization.

9. Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer.

1. Cutaneous Cell-Mediated Delayed Hypersensitivity to Intravitreal Bevacizumab.